XL IGL

Break Apart Probe

Order Number
D-5033-100-OG
Package Size
100 µl
Labels
  
Chromosome
22

Description

XL IGL

This product has been replaced by XL 22q11 IGL BA. Order Number D-5117-100-OG

Clinical Details

Primary karyotypic changes in lymphoid neoplasms commonly juxtapose oncogenes to the potent transcriptional enhancers associated with IG and TCR loci in B and T cells, respectively, often resulting in elevated levels of protein expression and loss of normal mechanisms of control. Less commonly, fusion genes are created that encode novel hybrid proteins.

Variant translocations involving the IG lambda (IGL) locus in 22q11 or the IG kappa (IGK) locus in 2p11.2 occur recurrently in B-cell neoplasias. The different translocations involving immunoglobulin genes have a diagnostic value and can be used to monitor the clinical course of the disease.

Clinical Applications

  • Non-Hodgkin Lymphomas (NHL)

Images

XL IGL

XL IGL hybridized to normal lymphocytes. Two normal interphases are shown.

Expected Patterns

Expected Pattern 1

Normal Cell:
Two green-orange fusion signals (2GO).

Expected Pattern 2

Aberrant Cell (typical results):
One green-orange fusion signal (1GO) and one green (1G), one orange (1O) indicating a chromosome break in the IGL locus.

Literature

  • Martin-Subero et al (2002) Int J Cancer 98:470-474
  • Einerson et al (2006) Leukemia 20:1790-1799

Downloads

Order Now or Request Assistance

Contact Us »

Contact MetaSystems directly or find your local MetaSystems partner.